Clinical Characteristics of Obstructive Sleep Apnea in Psychiatric Disease

被引:27
作者
Knechtle, Beat [1 ]
Economou, Nicholas-Tiberio [2 ]
Nikolaidis, Pantelis T. [3 ]
Velentza, Lemonia [2 ]
Kallianos, Anastasios [2 ]
Steiropoulos, Paschalis [4 ]
Koutsompolis, Dimitrios [2 ]
Rosemann, Thomas [1 ]
Trakada, Georgia [2 ]
机构
[1] Univ Zurich, Inst Primary Care, CH-8091 Zurich, Switzerland
[2] Univ Athens, Alexandra Hosp, Sch Med, Div Pulmonol,Dept Clin Therapeut, Athens 11528, Greece
[3] Exercise Physiol Lab, Nikaia 18450, Greece
[4] Democritus Univ Thrace, Univ Hosp Alexandroupolis, Med Sch, Dept Pulmonol, Alexandroupolis 68100, Greece
关键词
obstructive sleep apnea; psychiatric disease; major depressive disorder; bipolar disorder; schizophrenia and psychotic disorder; sleep study; METABOLIC SYNDROME; LUNG-FUNCTION; OBESITY; PREVALENCE; DEPRESSION; DISORDERS; PRESSURE; SCHIZOPHRENIA; ASSOCIATION; POPULATION;
D O I
10.3390/jcm8040534
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with serious psychiatric diseases (major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia and psychotic disorder) often complain about sleepiness during the day, fatigue, low energy, concentration problems, and insomnia; unfortunately, many of these symptoms are also frequent in patients with Obstructive Sleep Apnea (OSA). However, existing data about the clinical appearance of OSA in Psychiatric Disease are generally missing. The aim of our study was a detailed and focused evaluation of OSA in Psychiatric Disease, in terms of symptoms, comorbidities, clinical characteristics, daytime respiratory function, and overnight polysomnography data. We examined 110 patients (56 males and 54 females) with stable Psychiatric Disease (Group A: 66 with MDD, Group B: 34 with BD, and Group C: 10 with schizophrenia). At baseline, each patient answered the STOP-Bang Questionnaire, Epworth Sleepiness Scale (ESS), Fatigue Severity Scale (FSS), and Hospital Anxiety and Depression Scale (HADS) and underwent clinical examination, oximetry, spirometry, and overnight polysomnography. Body Mass Index (BMI), neck, waist, and hip circumferences, and arterial blood pressure values were also measured. The mean age of the whole population was 55.1 +/- 10.6 years. The three groups had no statistically significant difference in age, BMI, hip circumference, and systolic and diastolic arterial blood pressure. Class II and III obesity with BMI > 35 kg/m(2) was observed in 36 subjects (32.14%). A moderate main effect of psychiatric disease was observed in neck (p = 0.044, (2) = 0.064) and waist circumference (p = 0.021, (2) = 0.078), with the depression group showing the lowest values, and in pulmonary function (Forced Vital Capacity (FVC, %), p = 0.013, (2) = 0.084), with the psychotic group showing the lowest values. Intermediate to high risk of OSA was present in 87.37% of participants, according to the STOP-Bang Questionnaire (3 positive answers), and 70.87% responded positively for feeling tired or sleepy during the day. An Apnea-Hypopnea Index (AHI) 15 events per hour of sleep was recorded in 72.48% of our patients. AHI was associated positively with male sex, schizophrenia, neck, and waist circumferences, STOP-Bang and ESS scores, and negatively with respiratory function. A large main effect of psychiatric medications was observed in waist circumference (p = 0.046, (2) = 0.151), FVC (%) (p = 0.027, (2) = 0.165), and in time spend with SaO(2) < 90% (p = 0.006, (2) = 0.211). Our study yielded that patients with Psychiatric Disease are at risk of OSA, especially men suffering from schizophrenia and psychotic disorders that complain about sleepiness and have central obesity and disturbed respiratory function. Screening for OSA is mandatory in this medical population, as psychiatric patients have significantly poorer physical health than the general population and the coexistence of the two diseases can further negatively impact several health outcomes.
引用
收藏
页数:12
相关论文
共 38 条
[31]  
Trakada G, 2008, PSYCHOPHARMACOL BULL, V41, P89
[32]   Sleep Apnea and its Association with the Stress System, Inflammation, Insulin Resistance and Visceral Obesity [J].
Trakada, Georgia ;
Chrousos, George P. ;
Vgontzas, Alexandros N. ;
Pejovic, Slobodanka .
SLEEP MEDICINE CLINICS, 2007, 2 (02) :251-261
[33]   Obstructive Sleep Apnea Syndrome in the Sao Paulo Epidemiologic Sleep Study [J].
Tufik, Sergio ;
Santos-Silva, Rogerio ;
Taddei, Jose Augusto ;
Azeredo Bittencourt, Lia Rita .
SLEEP MEDICINE, 2010, 11 (05) :441-446
[34]   Validation of the Fatigue Severity Scale in a Swiss Cohort [J].
Valko, Philipp O. ;
Bassetti, Claudio L. ;
Bloch, Konrad E. ;
Held, Ulrike ;
Baumann, Christian R. .
SLEEP, 2008, 31 (11) :1601-1607
[35]   Metabolic syndrome and lung function in schizophrenia: A pilot study [J].
Vancampfort, Davy ;
Probst, Michel ;
Stubbs, Brendon ;
Soundy, Andrew ;
De Herdt, Amber ;
De Hert, Marc .
PSYCHIATRY RESEARCH, 2014, 220 (1-2) :58-62
[36]  
*WHO COLL CTR DRUG, 2017, GUID ATC CLASS DDD A
[37]   Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women [J].
Young, T ;
Evans, L ;
Finn, L ;
Palta, M .
SLEEP, 1997, 20 (09) :705-706
[38]   THE HOSPITAL ANXIETY AND DEPRESSION SCALE [J].
ZIGMOND, AS ;
SNAITH, RP .
ACTA PSYCHIATRICA SCANDINAVICA, 1983, 67 (06) :361-370